@whytee @DocMcstuffins
I distinctly recall SI saying in one webcast a few years ago MSB would be willing to run a RCT in high risk adults against something approved and therefore Ruxolitinib if that's what the FDA required.
I can't find the link now but prior to this (at least a year), I also distinctly recall an interview with KOL Dr. Susan Prockop saying that after her center's experience of treating 3 patients with Rux (She was very specific about the effects) they wouldn't be participating in a clinical trial.
Why would she say this unless she'd been asked?
I'd be grateful if you could both answer the following questions "yes" or "no"
1. Is it a fact that Dr Prockop was never asked to participate in a RCT in Ryoncil?
2. Is it your opinion that if a randomised controlled study in adults did go ahead and showed no efficacy (unlikely IMO), that would be proof it wasn't effective in children either?
@whytee @DocMcstuffinsI distinctly recall SI saying in one...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.020(1.73%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.17 | $16.67M | 14.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 54704 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.020 ( 3.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.17 | 2927691 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| MSB (ASX) Chart |